Publications by authors named "Qunjiang Wang"
Front Oncol
September 2024
Article Synopsis
- Immune checkpoint inhibitors (ICIs) like sintilimab are used to help fight cancer but can cause harmful side effects, including heart issues known as myocarditis.
- A 69-year-old man with cancer developed myocarditis after his treatment and initially felt fine, but then had serious problems like pneumonia and shock despite treatment.
- This case is special because it shows the importance of monitoring patients on sintilimab for heart issues and highlights the need to be aware of side effects from the steroids used to treat those problems.
Front Immunol
November 2023
Article Synopsis
- Immune checkpoint inhibitors (ICIs) like tislelizumab have shown effectiveness in treating cancer but can lead to unique immune-related adverse events (irAEs) that affect various organs.
- A case study of a 27-year-old male with thymic carcinoma showed that he developed severe abdominal and back pain after treatment, which was linked to ICI-induced ureteritis/cystitis despite initial treatments not providing relief.
- Discontinuing tislelizumab and administering methylprednisolone significantly improved his symptoms, highlighting the importance of recognizing and treating irAEs in cancer therapy.
